Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus

Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus

Abstract Use of galectin-3 for assessing cardiac function in prediabetes and type 2 diabetes mellitus (T2DM) needs to be established. Within the Gutenberg Health Study cohort (N = 15,010, 35–74 years) patient characteristics were investigated regarding galectin-3 levels. Prognostic value of galectin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Volker H. Schmitt, Jürgen H. Prochaska, Annegret S. Föll, Andreas Schulz, Karsten Keller, Omar Hahad, Thomas Koeck, Sven-Oliver Tröbs, Steffen Rapp, Manfred Beutel, Norbert Pfeiffer, Konstantin Strauch, Karl J. Lackner, Thomas Münzel, Philipp S. Wild
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/1271f9e7354d4fb6bc7fa4de94870c45
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/1271f9e7354d4fb6bc7fa4de94870c45

Documents similaires